OH2 Administered by Intratumoral Injection
Clinical trial NCT05954091 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05954091
- Sponsor
- Binhui Biopharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2027-07-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.